Sah, Dinah W.

Publishing since 2002 (Junior)

Has published 8 publications in 9 years

Number of publications published per year by Sah, Dinah W.. (Source : PubMed)

Distribution of publications types for Sah, Dinah W.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Chen Q, Butler D, Querbes W, Pandey RK, Ge P, Maier MA, Zhang L, Rajeev KG, Nechev L, Kotelianski V, Manoharan M, Sah DW. Lipophilic siRNAs mediate efficient gene silencing in oligodendrocytes with direct CNS delivery. J Control Release 2010
Love KT, Mahon KP, Levins CG, Whitehead KA, Querbes W, Dorkin JR, Qin J, Cantley W, Qin LL, Racie T, Frank-Kamenetsky M, Yip KN, Alvarez R, Sah DW, de Fougerolles A, Fitzgerald K, Koteliansky V, Akinc A, Langer R, Anderson DG. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl. Acad. Sci. U.S.A. 2010;107;5
Tritz R, Mueller BM, Hickey MJ, Lin AH, Gomez GG, Hadwiger P, Sah DW, Muldoon L, Neuwelt EA, Kruse CA. siRNA Down-regulation of the PATZ1 Gene in Human Glioma Cells Increases Their Sensitivity to Apoptotic Stimuli. Cancer Ther 2008;6;B
DiFiglia M, Sena-Esteves M, Chase K, Sapp E, Pfister E, Sass M, Yoder J, Reeves P, Pandey RK, Rajeev KG, Manoharan M, Sah DW, Zamore PD, Aronin N. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc. Natl. Acad. Sci. U.S.A. 2007;104;43
Sah DW. Therapeutic potential of RNA interference for neurological disorders. Life Sci. 2006;79;19
Lee DH, Strittmatter SM, Sah DW. Targeting the Nogo receptor to treat central nervous system injuries. Nat Rev Drug Discov 2003;2;11
Gardell LR, Wang R, Ehrenfels C, Ossipov MH, Rossomando AJ, Miller S, Buckley C, Cai AK, Tse A, Foley SF, Gong B, Walus L, Carmillo P, Worley D, Huang C, Engber T, Pepinsky B, Cate RL, Vanderah TW, Lai J, Sah DW, Porreca F. Multiple actions of systemic artemin in experimental neuropathy. Nat. Med. 2003;9;11
Sah DW, Ossipo MH, Porreca F. Neurotrophic factors as novel therapeutics for neuropathic pain. Nat Rev Drug Discov 2003;2;6

[ See timeline ] [ See all publications ]

Key figures

8 pub in 9 years
0.9 publications/year
best year 2003 with 3 pub
h-index 0 with 8 pub
h-ratio : 0 %

See Timeline

Ranking

It's me !

Click here if you are
Sah, Dinah W..

Most frequent Journals

Proc. Natl. Acad. Sci. U.S.A. (3x)
Nat Rev Drug Discov (2x)
Nat. Med. (1x)
J Control Release (1x)
Cancer Ther (1x)

Main affiliation

Alnylam Pharmaceuticals Inc., 300 Third Street, Cambridge, MA 02142, USA.

Latest co-workers

Alvarez R Anderson DG Frank-Kamenetsky M Gardell LR Ge P Hickey MJ Langer R Levins CG Manoharan M Pandey RK Porreca F Querbes W Rajeev KG Reeves P Rossomando AJ Tritz R Vanderah TW Yoder J Zamore PD Zhang L

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.